Lynda Charters

Investigators advised that further studies should be conducted to understand more precisely the benefits and risks

Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry

Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)

Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma

Austrian investigators recommend an interdisciplinary, rheumatologic–ophthalmologic approach to disease management

A retrospective observational study shows BCVA was maintained after 6 months for patients with neovascular AMD

Moving toward eliminating drug and chemical safety testing in animals

Bilateral distribution of the transgene seen with unilateral injection

Investigators sought to estimate the costs of treating GA with pegcetacoplan and to identify possible utility measures to compare treatments for GA

Data demonstrated that spontaneous macular hole closure and surgical treatment in paediatric patients appeared to be associated with comparable rates of closure and visual outcomes

Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution

There's much to do and see in San Francisco, where the American Academy of Ophthalmology (AAO) 2023 annual meeting will run from Friday 3 November through Monday 6 November

Data from the study, presented at the 2023 American Academy of Ophthalmology meeting in San Francisco, support the implantation of the LAL in eyes that had undergone a previous RK

The findings showed significant correlations between positive bacterial cultures and severe ROP, which requires diode laser and anti-VEGF treatment

Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual EURETINA Congress in Amsterdam, the Netherlands

Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications

Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world

Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops

Stem cells may replace some lost retinal neurons

The AI retinal scanning model will be free to use for all institutions

Commonly used immunosuppressants used in the short term to control an ocular inflammatory disease were not associated with increased risk of developing cancer later.

Researchers have identified markers that indicate the presence of Parkinson disease in patients an average of 7 years before the disease presents clinically.

The first-line treatment to avoid visual impairment for these cases is anti-vascular endothelial growth factor therapy (VEGF).

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.

This study of patients was designed to identify unexpected adverse effects of these new pharmacologic therapies that may not have been observed or anticipated during clinical research trials. The studied drugs were biosimilars to the reference drug ranibizumab.

Researchers indicated OCT can be vital to a timely diagnosis and treatment for scleritic patients.

Investigators found that implementing immediately sequential bilateral cataract surgery reduced the number of patient visits by 50%.

The authors suggested that future studies of myopia control should test stronger concentrations of atropine.

The 2023 41st annual meeting of the American Society of Retina Specialists (ASRS) will run from Thursday, July 27 to Tuesday, August 1 in Seattle, a city filled with sightseeing, museums, and great food to explore.

ASRS is an international, state-or-the-art event offering something for everyone: scientific papers, posters, panel discussions on controversial issues and techniques, award lectures, a Retina Case Conference, the 25th Annual Film Festival, international symposia, and subspecialty review courses.